Design of anticancer lysophosphatidic acid agonists and antagonists.
about
The autotaxin-lysophosphatidic acid-lysophosphatidic acid receptor cascade: proposal of a novel potential therapeutic target for treating glioblastoma multiformeAM966, an Antagonist of Lysophosphatidic Acid Receptor 1, Increases Lung Microvascular Endothelial Permeability through Activation of Rho Signaling Pathway and Phosphorylation of VE-Cadherin
P2860
Design of anticancer lysophosphatidic acid agonists and antagonists.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Design of anticancer lysophosphatidic acid agonists and antagonists.
@en
type
label
Design of anticancer lysophosphatidic acid agonists and antagonists.
@en
prefLabel
Design of anticancer lysophosphatidic acid agonists and antagonists.
@en
P2860
P356
P1476
Design of anticancer lysophosphatidic acid agonists and antagonists.
@en
P2093
Abby L Parrill
P2860
P304
P356
10.4155/FMC.14.52
P577
2014-05-01T00:00:00Z